\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationOnline
ProgrammesThis webinar looks at the EuroHPC AI Factories ecosystem, including AI Factories, future AI Gigafactories and AIF Antennas across Europe. he agenda includes presentations on AI Factories, AIF Antennas and Gigafactories, call types for industry, SMEs and academia, and user support services, followed by examples from awarded projects.
The webinar is designed to give researchers, start-ups, SMEs, and companies an overview of EuroHPC AI Factories calls, the evaluation process, and support options from the projects MINERVA and FFplus.
Speakers from the EuroHPC Joint Undertaking and related projects aim to explain the available access tracks for SMEs and academia, the support services on offer, and practical lessons from funded user projects. Two success stories are set to show how EuroHPC resources can support AI work in life sciences and atmospheric physics.
More information on the webinar and the possibility to register can be found on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
